OLANZAPINE LONG-ACTING INJECTION: AN 8-WEEK DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY IN ACUTELY-ILL PATIENTS WITH SCHIZOPHRENIA

Authors

Publication/Presentation Date

6-2008

Volume

102

Issue

1

First Page

251

Last Page

251

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS